Eli Lilly and Company today announced an arrangement to partner with Roche Diagnostics on its ongoing development of a commercially scalable cerebrospinal fluid assay for amyloid-beta 1-42.
from Dementia Big http://ift.tt/20u4D3J via alcoholic dementia
http://ift.tt/1Uspq3O
No comments:
Post a Comment